title: Does intravenous 6-mercaptopurine decrease salvage after relapse in childhood acute lymphoblastic leukemia?
authors.forename: Donald H
authors.initials: DH
authors.lastname: Mahoney
authors.forename: Bruce M
authors.initials: BM
authors.lastname: Camitta
authors.forename: Meenakshi
authors.initials: M
authors.lastname: Devidas
mesh_terms: D000284:Administration, Oral; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D018572:Disease-Free Survival; D006801:Humans; D007262:Infusions, Intravenous; D015122:Mercaptopurine / Q000008:administration & dosage*; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000401:mortality; D016032:Randomized Controlled Trials as Topic; D016879:Salvage Therapy
chemical_list: D000964:Antimetabolites, Antineoplastic; D015122:Mercaptopurine